As proof-of-concept, carbohydrate antigen 15-3 (CA15-3) and carcinoembryonic antigen (CEA) were selected as target biomarkers for breast cancer screening and broader cancer indication, respectively. Here, CEACAM5 is linked to breast carcinoma.